Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat
Authors:
- Bernardo Rodríguez-IturbeBRBernardo Rodríguez-Iturbe
- Yasmir QuirozYQYasmir Quiroz
- Ashkan ShahkaramiASAshkan Shahkarami
- Zhen LiZLZhen Li
- Nosratola D. VaziriNVNosratola D. Vaziri
- 1 September 2005
- journal article
- Published by Elsevier in Kidney International
- Vol. 68 (3) , 1041-1047
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Upregulation of Angiotensin II Type 1 Receptor, Inflammatory Mediators, and Enzymes of Arachidonate Metabolism in Obese Zucker Rat KidneyCirculation, 2005
- AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia, and glomerulosclerosis in the Imai ratKidney International, 2004
- ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker ratsKidney International, 2004
- Cytoskeletal Reorganization by Mycophenolic Acid Alters Mesangial Cell Migration and ContractilityHypertension, 2003
- Mycophenolic acid antagonizes the activation of cultured human mesangial cellsKidney International, 2002
- Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failureKidney International, 2001
- Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidneyKidney International, 2000
- The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury.Hypertension, 1992
- Treatment of hyperlipidemia reduces glomerular injury in obese Zucker ratsKidney International, 1988
- Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl ratsKidney International, 1984